AmorChem
Montreal, QC
Investment Thesis
AmorChem is Canada's premier early-stage life sciences venture fund focused on creating next-generation biotech companies from academic research. The fund specializes in translational research and therapeutic discovery across disease areas, investing in the earliest spark of innovation where fundamental science meets commercial potential.
Focus Areas
Investment Stage
Pre-SeedSeed
Sectors
Investment Signals
GeographyCanada-focused
ProvincesQC
RoleLead
Revenue Stagepre-revenue ok
Impact MandateYes
Business Modelsdeep-tech, IP-licensing
Sample Portfolio Companies
Kodikaz Therapeutic Solutions, Inc.
AUM & Sources
Est. C$46M
Assets under management (estimated)
Sources
No public sources found.
Raising from Canadian VCs?Get AI-matched to your top investors in seconds.
Find My Investors →Similar Funds
See incorrect information?
Help us keep this directory accurate and up to date.